CNVVF
Price
$3.35
Change
-$0.13 (-3.74%)
Updated
Aug 15 closing price
Capitalization
6.53B
GKOS
Price
$94.05
Change
+$3.91 (+4.34%)
Updated
Sep 5, 04:59 PM (EDT)
Capitalization
5.39B
54 days until earnings call
Interact to see
Advertisement

CNVVF vs GKOS

Header iconCNVVF vs GKOS Comparison
Open Charts CNVVF vs GKOSBanner chart's image
ConvaTec Group
Price$3.35
Change-$0.13 (-3.74%)
Volume$100
Capitalization6.53B
Glaukos
Price$94.05
Change+$3.91 (+4.34%)
Volume$10.06K
Capitalization5.39B
CNVVF vs GKOS Comparison Chart in %
Loading...
CNVVF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GKOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CNVVF vs. GKOS commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNVVF is a Hold and GKOS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (CNVVF: $3.35 vs. GKOS: $90.14)
Brand notoriety: CNVVF and GKOS are both not notable
CNVVF represents the Pharmaceuticals: Other, while GKOS is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: CNVVF: 0% vs. GKOS: 124%
Market capitalization -- CNVVF: $6.53B vs. GKOS: $5.39B
CNVVF [@Pharmaceuticals: Other] is valued at $6.53B. GKOS’s [@Medical/Nursing Services] market capitalization is $5.39B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $162.93B to $0. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $231.38B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.95B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.65B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CNVVF’s FA Score shows that 1 FA rating(s) are green whileGKOS’s FA Score has 0 green FA rating(s).

  • CNVVF’s FA Score: 1 green, 4 red.
  • GKOS’s FA Score: 0 green, 5 red.
According to our system of comparison, CNVVF is a better buy in the long-term than GKOS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CNVVF’s TA Score shows that 2 TA indicator(s) are bullish while GKOS’s TA Score has 3 bullish TA indicator(s).

  • CNVVF’s TA Score: 2 bullish, 1 bearish.
  • GKOS’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, CNVVF is a better buy in the short-term than GKOS.

Price Growth

CNVVF (@Pharmaceuticals: Other) experienced а 0.00% price change this week, while GKOS (@Medical/Nursing Services) price change was -6.65% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.39%. For the same industry, the average monthly price growth was +7.03%, and the average quarterly price growth was +18.51%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -0.21%. For the same industry, the average monthly price growth was +4.14%, and the average quarterly price growth was +25.02%.

Reported Earning Dates

GKOS is expected to report earnings on Oct 29, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-1.39% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical/Nursing Services (-0.21% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CNVVF($6.53B) has a higher market cap than GKOS($5.39B). CNVVF YTD gains are higher at: 15.917 vs. GKOS (-39.883). CNVVF has higher annual earnings (EBITDA): 567M vs. GKOS (-47.8M). GKOS has more cash in the bank: 275M vs. CNVVF (95.7M). GKOS has less debt than CNVVF: GKOS (105M) vs CNVVF (1.34B). CNVVF has higher revenues than GKOS: CNVVF (2.36B) vs GKOS (433M).
CNVVFGKOSCNVVF / GKOS
Capitalization6.53B5.39B121%
EBITDA567M-47.8M-1,186%
Gain YTD15.917-39.883-40%
P/E Ratio31.60N/A-
Revenue2.36B433M544%
Total Cash95.7M275M35%
Total Debt1.34B105M1,276%
FUNDAMENTALS RATINGS
CNVVF vs GKOS: Fundamental Ratings
CNVVF
GKOS
OUTLOOK RATING
1..100
4272
VALUATION
overvalued / fair valued / undervalued
1..100
25
Undervalued
95
Overvalued
PROFIT vs RISK RATING
1..100
5861
SMR RATING
1..100
8694
PRICE GROWTH RATING
1..100
5959
P/E GROWTH RATING
1..100
6760
SEASONALITY SCORE
1..100
6510

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CNVVF's Valuation (25) in the null industry is significantly better than the same rating for GKOS (95) in the Medical Specialties industry. This means that CNVVF’s stock grew significantly faster than GKOS’s over the last 12 months.

CNVVF's Profit vs Risk Rating (58) in the null industry is in the same range as GKOS (61) in the Medical Specialties industry. This means that CNVVF’s stock grew similarly to GKOS’s over the last 12 months.

CNVVF's SMR Rating (86) in the null industry is in the same range as GKOS (94) in the Medical Specialties industry. This means that CNVVF’s stock grew similarly to GKOS’s over the last 12 months.

CNVVF's Price Growth Rating (59) in the null industry is in the same range as GKOS (59) in the Medical Specialties industry. This means that CNVVF’s stock grew similarly to GKOS’s over the last 12 months.

GKOS's P/E Growth Rating (60) in the Medical Specialties industry is in the same range as CNVVF (67) in the null industry. This means that GKOS’s stock grew similarly to CNVVF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CNVVFGKOS
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
89%
Stochastic
ODDS (%)
N/A
Bearish Trend 2 days ago
75%
Momentum
ODDS (%)
Bullish Trend 2 days ago
36%
Bearish Trend 2 days ago
63%
MACD
ODDS (%)
Bullish Trend 2 days ago
33%
Bullish Trend 2 days ago
76%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
29%
Bearish Trend 2 days ago
69%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
16%
Bullish Trend 2 days ago
76%
Advances
ODDS (%)
N/A
Bullish Trend 9 days ago
78%
Declines
ODDS (%)
N/A
Bearish Trend 4 days ago
68%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
70%
Aroon
ODDS (%)
Bearish Trend 2 days ago
28%
Bearish Trend 2 days ago
72%
View a ticker or compare two or three
Interact to see
Advertisement
CNVVF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GKOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VBINX51.36N/A
N/A
Vanguard Balanced Index Inv
SCRLX78.91N/A
N/A
Touchstone Large Cap Focused Instl
BIVSX18.69N/A
N/A
Invenomic Super Institutional
HLIDX14.79N/A
N/A
Harding Loevner Intl Dev Mkts Eq Inst
VGISX35.18N/A
N/A
Virtus Duff & Phelps Glb Rl Estt Secs I

CNVVF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CNVVF has been loosely correlated with FLMNY. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if CNVVF jumps, then FLMNY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNVVF
1D Price
Change %
CNVVF100%
N/A
FLMNY - CNVVF
36%
Loosely correlated
N/A
SAFLY - CNVVF
32%
Poorly correlated
N/A
GKOS - CNVVF
24%
Poorly correlated
-4.58%
EW - CNVVF
23%
Poorly correlated
-0.32%
OFIX - CNVVF
22%
Poorly correlated
-0.34%
More

GKOS and

Correlation & Price change

A.I.dvisor indicates that over the last year, GKOS has been loosely correlated with ISRG. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if GKOS jumps, then ISRG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GKOS
1D Price
Change %
GKOS100%
-4.58%
ISRG - GKOS
51%
Loosely correlated
+3.02%
NTRA - GKOS
48%
Loosely correlated
-0.58%
ITGR - GKOS
48%
Loosely correlated
+0.72%
RDNT - GKOS
48%
Loosely correlated
+1.90%
DXCM - GKOS
47%
Loosely correlated
+2.33%
More